Suzhou NeuPharma Co., Ltd announced that it has initiated the first-in-human Phase I clinical trial of RX108 in Australia.
Dr. Chunlin Chen, Medicilon’s CEO, was the host of the seminar in Tokyo and Osaka and gave a wonderful speech with the topic “Current Pharmaceutical Industry and New Drug Transaction in China” during the seminars.
CCTV NEWS English Channel launched the special news program, “Free Trade Zone Self-Break and Outlook” during the “Lianghui”, the annual plenary sessions.
The 2015 Shanghai Medicilon and Medicilon Preclinical Annual Dinner was successfully held on Feb 6. Medicilon wish you a Happy New Year.
Pharmaceutical innovation is the energy to upgrade the industrial structure. The First Guangzhou Multinational Pharmaceutical R&D Summit...